The inspection of medicaments is now aligned between Switzerland and the United States, with the aim of saving on paperwork and cost for the pharmaceutical industry.
This content was published on
1 minute
swissinfo.ch/mga
The Mutual Recognition Agreement (MRA) for inspection of medicinal products came into force on Thursday. The deal allows authorities from both countries to share documents from their routine inspections of pharmaceutical manufacturing facilities, thus erasing duplication of efforts in each country.
This agreement comes as the complexities of foreign production and sourcing in supply chains for medicine increase, making them more difficult and costly to monitor.
The respective inspection authorities, Swissmedic and the Food and Drug Administration, are working towards extending the inspection alignment to vaccines.
After the European Union, the US is the second-most important trading partner for research-based pharmaceutical companies in Switzerland. In 2021, the US accounted for 26% of Swiss pharma exports (CHF109 billion) and 10% of imports.
A similar medicaments MRA between the EU and Switzerland on pharmaceutical products is expected to expire in a few years. But the current political impasse between the two parties.
If the arrangement isn’t renewed, Swiss companies would need to conduct multiple checks and inspections, which could cost the sector an estimated CHF500 million ($558 million) a year in extra costs.
Popular Stories
More
Swiss Politics
Swiss reject plans for bigger motorways and extra rights for landlords
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Argentina’s Milei to visit Switzerland in January 2025
This content was published on
Argentina's libertarian President Javier Milei plans to visit Switzerland on January 24, 2025 to attend an event organised by the Liberal Institute in Zurich.
This content was published on
OpenAI, the maker of ChatGPT, says it intends to open an office in Zurich. The move is part of its European expansion plan, after setting up offices in London, Paris, Brussels and Dublin.
This content was published on
The Swiss economy is growing slightly faster than expected, according to the Organization for Economic Cooperation and Development (OECD).
This content was published on
The House of Representatives on Wednesday cut the foreign aid budget by CHF250 million ($282 million) in favour of the army.
Parliament confirms 13th pension payment to be paid once a year in December
This content was published on
The 13th old-age pension payment will be paid out as planned from December 2026, the Swiss Senate confirmed on Wednesday.
This content was published on
Around 1,000 Swiss farmers took part in a protest action near Bern on Tuesday, calling for less administrative work, more planning security and fairer prices.
UN appeals for more funds to assist 305 million people in need
This content was published on
The United Nations Office for the Coordination of Humanitarian Affairs (OCHA) estimates that around 305 million people will need aid in 2025.
Swiss authorities release right-to-die activist in Sarco ‘suicide capsule’ case
This content was published on
A right-to-die activist has been released from police custody over the reported first use of the Sarco “suicide capsule”, after prosecutors ruled out the possibility of an intentional homicide.
Switzerland demands immediate halt to hostilities in Syria
This content was published on
The Swiss foreign ministry has called for an immediate end to hostilities in Syria. International humanitarian law must be respected, it declared via the social media platform X on Tuesday.
Poll: right-wing Swiss People’s Party enjoys growing support among population
This content was published on
If national elections had been held in Switzerland last month, the right-wing Swiss People's Party would have won, and increased its share of votes by 2% compared to the 2023 federal elections.
Switzerland and US sign deal on pharmaceutical supply chain
This content was published on
US and Swiss authorities have agreed to share inspection documents on pharmaceutical manufacturing facilities in a move to improve efficiency and safety.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.